Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
T Cell Types and Functions01:24

T Cell Types and Functions

2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunological analysis of Blau syndrome, a unique autoinflammatory state.

Frontiers in immunology·2026
Same author

Intestinal Inflammation Impacts Gestational Weight Gain in Women With Inflammatory Bowel Disease and Growth in Offspring.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Associations Between Cannabis Use and Inflammatory Biomarkers Among People with HIV.

Cannabis and cannabinoid research·2026
Same author

Additive effects of common and rare genetic variants on inflammatory bowel disease risk in a cohort with immunodeficiency.

The Journal of allergy and clinical immunology·2026
Same author

Clinical relevance of mosaic variants detected by exome sequencing.

The Journal of allergy and clinical immunology·2026
Same author

<i>ROBO2</i> Variants Associated With Atrial Septal Defect Define a Novel Regulatory Element.

Circulation. Genomic and precision medicine·2026

Related Experiment Video

Updated: Jan 11, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1&#946; in Human Monocyte-derived Dendritic Cells
09:04

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

21.4K

LRRK2-mediated NLRC4 phosphorylation differentially regulates IL-1β/IL-18 secretion.

Sharmina Deloer1, Ivan Fuss1, Portia Gough2

  • 1Mucosal Immunology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, United States.

Frontiers in Immunology
|November 17, 2025
PubMed
Summary
This summary is machine-generated.

LRRK2-kinase phosphorylation regulates the NLRC4 inflammasome, impacting IL-1β production and gut barrier function. Inhibition of LRRK2-kinase in Crohn

Keywords:
Crohn’s diseaseLRRK2NLRC4inflammasomeinflammation

More Related Videos

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions
08:40

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions

Published on: March 14, 2016

20.1K
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

7.9K

Related Experiment Videos

Last Updated: Jan 11, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1&#946; in Human Monocyte-derived Dendritic Cells
09:04

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

21.4K
An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions
08:40

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions

Published on: March 14, 2016

20.1K
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

7.9K

Area of Science:

  • Immunology
  • Molecular Biology
  • Gastroenterology

Background:

  • The NLRC4 inflammasome plays a critical role in innate immunity and inflammatory diseases.
  • LRRK2 kinase activity is implicated in inflammatory conditions, including Crohn's disease (CD).
  • The precise relationship between LRRK2 and NLRC4 inflammasome function remains incompletely understood.

Purpose of the Study:

  • To investigate the role of LRRK2-kinase phosphorylation in NLRC4 inflammasome activation and function.
  • To explore the impact of LRRK2-mediated NLRC4 inflammasome regulation on IL-1β and IL-18 production.
  • To examine the therapeutic potential of LRRK2 inhibition in modulating NLRC4 inflammasome activity in Crohn's disease models.

Main Methods:

  • Analysis of LRRK2-kinase phosphorylation of the NLRC4 inflammasome in human and murine cells.
  • Assessment of inflammasome activation and cytokine production (IL-1β, IL-18) following LRRK2 inhibition.
  • Studies in wild-type and genetically modified mice to evaluate NLRC4 inflammasome-induced gut barrier dysfunction.

Main Results:

  • LRRK2-kinase is essential and sufficient for NLRC4 inflammasome phosphorylation, requiring ASC association.
  • LRRK2 inhibition impairs IL-1β production by modulating pro-IL-1β cleavage but not IL-18 production.
  • Increased NLRC4 inflammasome activation and LRRK2-dependent IL-1β secretion were observed in cells from CD patients.
  • NLRC4 inflammasome activation impairs gut barrier function, an effect abrogated by LRRK2-kinase inhibition.

Conclusions:

  • LRRK2-kinase phosphorylation is a key regulator of NLRC4 inflammasome function, specifically impacting IL-1β production.
  • LRRK2 inhibition demonstrates therapeutic potential by mitigating NLRC4-mediated gut barrier dysfunction in CD.
  • Targeting LRRK2 offers a strategy to selectively modulate inflammasome activity and ameliorate inflammatory pathology.